# Lab Thread

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lab-thread

- Industry: Software
- Headquarters: UK
- Website: www.labthread.com
- Total disclosed funding: $1M
- Latest round: Seed (Jun 4, 2025)
- Investors on record: 1

## About

Lab Thread Ltd., based in the UK, specializes in software solutions that streamline laboratory management, integrating research projects, lab operations, and scientific data for enhanced efficiency.Lab Thread Ltd. was founded in 2024 in the UK, focusing on creating a software platform for laboratory management. The company has engaged in 1 deal, with its most recent funding round occurring on July 7, 2025, led by Mercia Asset Management, raising GBP 750,000. No significant changes in business strategy have been mentioned, and there is no reference to subsidiaries or mergers. The founder's history is not available, but the company has positioned itself as an innovative player in laboratory software.Lab Thread offers a comprehensive software platform designed to integrate research projects, lab operations, and scientific data, facilitating streamlined laboratory management for researchers and organizations. The core functionalities of the platform include project management, molecular biology tools for sequence design and simulation, standardized in-lab processes, and an electronic laboratory notebook (ELN) compliant with 21 CFR Part 11 regulations. It addresses critical use cases such as data capture, sample tracking, and inventory management, enhancing the efficiency of scientific workflows. The platform is expected to enter beta testing in autumn 2025, targeting research institutions, biotech companies, and academic laboratories across North America and Europe.Lab Thread's revenue generation model is structured around subscription services for its software platform, providing users with tools for managing scientific data and lab operations. Clients engage in annual or monthly subscription agreements that grant access to functionalities including integrated LIMS, ELN, and sequence design tools. The business-to-business (B2B) model primarily targets research institutions and biotech firms requiring robust data management solutions. Specific pricing plans have not been disclosed, but offerings likely include tiered subscriptions catering to varying organizational sizes and research needs.In July 2025, Lab Thread Ltd. raised GBP 750,000 in venture funding, led by Mercia Asset Management, to support the further development of its platform. The company plans to launch new products, with beta testing for its platform slated for autumn 2025. Lab Thread aims to expand its market presence across North America and Europe, focusing on research institutions and biotech companies as key segments for growth.

## Funding rounds

- Seed, Jun 4, 2025, $1M — Mercia Asset Management

## Investors

- Mercia Asset Management (https://capitalatlas.ai/funds/mercia-asset-management) — Seed